Post-thrombotic syndrome (PTS) is a chronic venous insufficiency manifestation following an
episode of deep-vein thrombosis (DVT). It is an important and frequent long-term adverse …

Catheter-directed thrombolysis (CDT) has been utilized as an adjunct to anticoagulant
therapy in selected patients with deep vein thrombosis (DVT) for approximately 30 years …

The postthrombotic syndrome (PTS) is chronic venous insufficiency secondary to a prior
deep vein thrombosis (DVT). It is the most common complication of venous …

Background Studies suggest that the direct factor Xa inhibitor rivaroxaban compared to
warfarin reduces the risk of post‐thrombotic syndrome (PTS) after deep vein thrombosis …

The incidence of post-thrombotic syndrome (PTS) in patients with deep vein thrombosis
(DVT) treated with direct oral anticoagulants (DOACs) remains a matter of debate. Hence …

Postthrombotic syndrome (PTS) remains one of the major late complications of deep vein
thrombosis (DVT) with a reported prevalence from 10 to 50%. Many factors were found to be …

Los anticoagulantes orales directos han surgido como una de las herramientas que ha
cambiado el manejo de la enfermedad trombótica en los últimos 15 años. Sus ventajas …

Background Post-thrombotic syndrome (PTS) is the main long-term complication of deep
vein thrombosis (DVT). Several therapies are being evaluated to prevent or to treat PTS …

Background Post-thrombotic syndrome (PTS) is common in patients with deep vein
thrombosis (DVT). It is unclear if different types of anticoagulant therapies (eg vitamin K …

Post-thrombotic syndrome and chronic thromboembolic pulmonary hypertension are two
distinct clinical syndromes associated with adverse patient outcomes following a venous …